Mahdi Bazzi1, Marcus L Jamil1, Ali A Dabaja2. 1. Henry Ford Health System, Vattikuti Urology Institute, 2799 West Grand Boulevard, Detroit, MI, 48202, USA. 2. Henry Ford Health System, Vattikuti Urology Institute, 2799 West Grand Boulevard, Detroit, MI, 48202, USA. Adabaja2@hfhs.org.
Abstract
PURPOSE OF REVIEW: To explore the potential hurdles surgeons may encounter when preforming surgical correction of penile curvature in patients with Peyronie's Disease following intralesional collagenase clostridium histolyticum injections. RECENT FINDINGS: Although limited data exists, retrospective analysis of surgeon experiences in surgical treatment of refractory penile curvature in patients with Peyronie's disease appears to not result in more post-operative complications and may only slightly increase intra-operative difficulty. As the use of intralesional collagenase clostridium histolyticum continues to increase and patients who demonstrate persistent curvature despite treatment seek further management, the role of investigating the feasibility of surgery demonstrates significant importance. Although limited data exists, it appears that surgery following intralesional collagenase clostridium histolyticum is safe without added post-operative complications. At the present time, however, further data on intra-operative findings and post-operative outcomes remain necessary, and as the use of this intralesional therapy continues to rise, further information should become readily available.
PURPOSE OF REVIEW: To explore the potential hurdles surgeons may encounter when preforming surgical correction of penile curvature in patients with Peyronie's Disease following intralesional collagenase clostridium histolyticum injections. RECENT FINDINGS: Although limited data exists, retrospective analysis of surgeon experiences in surgical treatment of refractory penile curvature in patients with Peyronie's disease appears to not result in more post-operative complications and may only slightly increase intra-operative difficulty. As the use of intralesional collagenase clostridium histolyticum continues to increase and patients who demonstrate persistent curvature despite treatment seek further management, the role of investigating the feasibility of surgery demonstrates significant importance. Although limited data exists, it appears that surgery following intralesional collagenase clostridium histolyticum is safe without added post-operative complications. At the present time, however, further data on intra-operative findings and post-operative outcomes remain necessary, and as the use of this intralesional therapy continues to rise, further information should become readily available.
Authors: G La Pera; E S Pescatori; M Calabrese; A Boffini; F Colombo; E Andriani; A Natali; L Vaggi; C Catuogno; M Giustini; F Taggi Journal: Eur Urol Date: 2001-11 Impact factor: 20.096
Authors: John P Mulhall; Steven D Creech; Stephen A Boorjian; Sam Ghaly; Edward D Kim; Ayham Moty; Rodney Davis; Wayne Hellstrom Journal: J Urol Date: 2004-06 Impact factor: 7.450
Authors: Andrea Cocci; David Ralph; Rados Djinovic; Georgios Hatzichristodoulou; Girolamo Morelli; Andrea Salonia; Paolo Capogrosso; Andrea Romano; Gianmartin Cito; Fabrizio Di Maida; Esaú Fernández-Pascual; Javier Romero-Otero; Paulo Egydio; Marco Falcone; Mirko Preto; Giovanni Chiriacò; Jack Beck; Maarten Albersen; Suks Minhas; Giovanni Cacciamani; Juan Ignacio Martinez Salamanca; Nicola Mondani; Andrea Minervini; Giorgio Ivan Russo Journal: Sci Rep Date: 2021-01-08 Impact factor: 4.379
Authors: Daniar Osmonov; Ahmed Ragheb; Sam Ward; Gideon Blecher; Marco Falcone; Armin Soave; Roland Dahlem; Koenraad van Renterghem; Nim Christopher; Georgios Hatzichristodoulou; Mirko Preto; Giulio Garaffa; Maarten Albersen; Carlo Bettocchi; Giovanni Corona; Yacov Reisman Journal: Sex Med Date: 2021-11-22 Impact factor: 2.491